Ephoran Multi Imaging Solutions is a preclinical CRO (Contract Research Organization) located in the Bio Industry Park of Canavese at Colleretto Giacosa (Torino, Italy), offering preclinical imaging services. In vivo preclinical imaging is the main specialization of Ephoran in particular for the evaluation of the contrastographic properties of novel contrast agents for different imaging techniques and for the application of imaging techniques in the assessment of the therapeutic properties of drugs.
Ephoran offers the opportunity to apply a translational pharmacological approach in drug research and development, this consists in evaluating in animal models a molecular-based proof of biological activity and mechanism of action, and translating it into the clinical setting. Expertise of Ephoran's founders guarantees outstanding knowledge in all imaging modalities and excellence in R&D activities.
Ephoran has access to a wide array of imaging technologies including MRI, CT, PET, SPECT bioluminescence and fluorescence imaging covering all aspects of molecular imaging from anatomical to functional and molecular levels. Imaging procedures have been developed for the most common xenograft, orthotopic and transgenic animal models to be used for research and development studies. Ephoran offers also preclinical pharmaco-toxicological, pharmacokinetics, and in vitro testing. Ephoran has developed strong and qualified scientific collaborations with academia and research institutions in order to develop state-of-the-art molecular and preclinical imaging in cells and laboratory animals.